ArticleSeminars in dialysis2022

Regional citrate and systemic heparin are adequate to maintain filter half-life for COVID-19 patients on continuous renal replacement therapy.

Cassandra Chiao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.